No definition available.
Cardiovascular disorders originating in the perinatal period
P16_CARDIOV_DISORD_ORIGINA_PERINA_PERIOD
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
134 |
4. Check minimum number of eventsNone |
134 |
5. Include endpointsNone |
134 |
6. Filter based on genotype QC (FinnGen only) |
134 |
Control definitions (FinnGen only)
- Control exclude
- P16_RESPI_CARDIOV_DISORD_SPECIFIC_PERINA_PERIOD
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P2
- Name in latin
- Morbositates cardiovasculares origine perinatales
Similar endpoints
↥List of similar endpoints to
Cardiovascular disorders originating in the perinatal period
based on the number of shared cases.
Similar with more cases:
- Respiratory and cardiovascular disorders specific to the perinatal period
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7884 | 3729 | 4154 |
| Only index persons | 4035 | 1874 | 2161 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.11 | 0.11 | 0.12 |
| Only index persons | 0.08 | 0.07 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.01 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 134 | 76 | 58 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 124
- Matched controls
- 1234
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P29.30
ICD-10 Finland
Delayed closure of the ductus arteriosus
+∞
51.7
46
*
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
+∞
36.2
33
*
P29.31
ICD-10 Finland
Persistent fetal circulation
+∞
33.9
31
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
20.7
32.8
51
40
P29.9
ICD-10 Finland
Cardiovascular disorder originating in the perinatal period, unspecified
+∞
29.3
27
*
P07.3
ICD-10 Finland
Other preterm infants
14.4
22.2
39
38
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
+∞
20.3
19
*
P07.2
ICD-10 Finland
Extreme immaturity
207.6
18.0
18
*
WX722
NOMESCO Finland
PEEP
18.2
15.6
24
16
J45.1
ICD-10 Finland
Nonallergic asthma
5.8
12.9
40
93
H35.1
ICD-10 Finland
Retinopathy of prematurity
+∞
12.7
12
*
WX730
NOMESCO Finland
Conventional respirator
20.7
12.4
18
10
P29.1
ICD-10 Finland
Neonatal cardiac dysrhythmia
+∞
11.6
11
*
FDE00
NOMESCO Finland
Closure of patent ductus arteriosus
+∞
10.5
10
*
P29.8
ICD-10 Finland
Other cardiovascular disorders originating in the perinatal period
+∞
10.5
10
*
Z2221
NOMESCO Finland
Medical doctor
3.8
10.5
56
218
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
5.9
9.7
28
58
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.4
9.6
38
112
Q25.0
ICD-10 Finland
Patent ductus arteriosus
9.8
9.1
18
21
P07.01
ICD-10 Finland
Extremely low birth weight 500-749 g
+∞
8.4
8
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.0
7.5
57
272
P07.02
ICD-10 Finland
Extremely low birth weight 750-999 g
+∞
7.3
7
*
602
Kela drug reimbursment
Children's severe malnutrition
5.1
7.3
23
53
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.4
7.3
39
146
RK312
NOMESCO Finland
NA
21.5
7.2
10
5
R4110
NOMESCO Finland
Physiotherapy
3.0
7.1
52
241
Z3231
NOMESCO Finland
Registered nurse
2.7
6.8
69
388
WX732
NOMESCO Finland
High frequency respirator
42.2
6.8
8
*
P07.10
ICD-10 Finland
Other low birth weight 1000-1499 g
23.9
6.8
9
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
6.7
55
271
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
73.1
6.5
7
*
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
5.3
6.4
19
41
ZX114
NOMESCO Finland
Intramuscular
7.7
6.4
14
20
WX882
NOMESCO Finland
High dependency care
3.3
6.3
35
133
RK320
NOMESCO Finland
NA
28.1
6.3
8
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
28.1
6.3
8
*
RK412
NOMESCO Finland
NA
+∞
6.3
6
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
6.3
50
242
XG413
NOMESCO Finland
Spirometry with oscillometry
6.6
6.2
15
25
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
10.8
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044640) Blood type and Crossmatch panel - Blood
54
279
2.56
6.27
3.6
3.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
48
243
2.51
5.73
3.3
3.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
57
347
2.11
4.19
5.0
4.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
22
90
2.72
3.94
1.8
1.7
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
7
10
7.29
3.40
1.7
1.0
%
132.1
117.0
—
7
10
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
11
32
3.64
3.40
27.6
6.1
%
53.5
57.7
0.20
11
32
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
11
33
3.53
3.25
2.8
2.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
39
3.27
3.16
1.5
2.1
—
—
—
0
0
(4035726)
13
46
3.01
3.00
1.7
2.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
64
2.69
2.98
1.6
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
64
2.69
2.98
1.6
1.5
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
6
9
6.89
2.89
1.5
1.1
%
79.5
82.8
—
6
9
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
6
9
6.89
2.89
3.0
1.1
%
80.0
87.2
—
6
9
(3030467) Casts [#/volume] in Urine by Automated count
53
351
1.84
2.83
5.1
4.8
e6/l
0.4
0.3
0.08
41
258
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
41
250
1.92
2.83
4.5
4.1
e6/l
2.4
2.3
0.03
25
145
(3002582) Erythrocytes [#/volume] in Urine
55
371
1.81
2.76
5.8
5.0
e6/l
1005.6
29.7
0.48
43
281
(3000494) Fungus identified in Specimen by Culture
20
93
2.34
2.76
1.3
1.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
60
419
1.77
2.66
7.1
6.0
e6/l
52.3
39.1
0.16
43
288
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
25
130
2.13
2.65
5.6
3.7
%
19.1
20.5
0.24
25
124
(36304419) Bacteria [Presence] in Urine
52
351
1.78
2.57
4.7
4.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
56
387
1.76
2.55
6.3
5.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
39
2.97
2.53
1.6
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
28
155
2.01
2.53
4.3
6.8
mg/l
1.3
2.6
0.85
18
121
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
39
242
1.86
2.53
3.2
4.0
e6/l
0.7
0.7
0.04
23
137
(3008037) Lactate [Moles/volume] in Venous blood
5
8
6.42
2.38
15.2
2.8
mmol/l
1.2
1.1
—
5
8
(3000330) Specific gravity of Urine by Test strip
9
29
3.24
2.26
3.3
2.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
48
2.64
2.24
1.6
2.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
9
30
3.13
2.18
5.0
4.5
umol/l
23.9
27.7
—
9
30
(3023368) Bacteria identified in Blood by Culture
30
179
1.86
2.17
3.6
4.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
14
4.42
2.17
8.5
12.9
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
20
3.62
2.08
2.3
2.7
—
—
—
0
0
(4306422)
6
15
4.12
2.05
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
22
364
0.52
2.05
1.9
2.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
19
99
2.06
2.01
2.2
2.6
iu/l
24.0
9.1
0.71
13
63
(4010399)
12
51
2.48
2.00
1.3
1.5
—
—
—
0
0
(3015736) pH of Urine
48
337
1.65
1.98
3.1
3.5
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
11
4.66
1.95
8.0
8.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
74
580
1.61
1.94
12.6
9.2
mmol/l
5.9
6.0
0.04
74
542
(3011397) Hemoglobin [Presence] in Urine by Test strip
40
271
1.67
1.87
3.2
3.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
56
415
1.59
1.83
7.1
5.6
estimate
0.0
0.0
—
10
71
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
9
35
2.67
1.83
3.4
4.9
%
93.9
90.8
—
9
35
(40758558) Short blood count panel - Blood
57
425
1.59
1.81
4.4
9.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
56
416
1.59
1.81
4.8
3.7
estimate
0.0
0.0
0.00
11
68
(3018418) pH of Serum or Plasma
32
206
1.72
1.80
8.8
4.2
ph
7.4
7.4
—
8
34
(3035350) Ketones [Presence] in Urine by Test strip
56
417
1.58
1.79
4.8
3.7
estimate
0.0
0.0
—
10
65
(1616796) Gas panel - Central venous blood
8
30
2.76
1.75
11.9
6.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
73
582
1.55
1.71
26.1
13.8
mmol/l
1.2
1.2
0.05
68
546
(3009214) Lutropin [Units/volume] in Serum or Plasma
19
106
1.92
1.68
2.2
2.6
u/l
9.7
5.1
0.47
11
64
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
19
3.25
1.67
1.0
1.1
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
7
25
2.89
1.67
2.6
3.9
mmol/l
15.6
17.3
—
7
25
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
56
2.25
1.65
1.5
1.9
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
5
14
3.65
1.62
1.0
1.3
%
80.4
91.4
—
5
14
(3003694) ABO and Rh group [Type] in Blood
46
334
1.57
1.61
2.0
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
72
578
1.52
1.59
4.8
4.0
—
25.1
—
0
7
(3022313) Gas panel - Capillary blood
44
317
1.57
1.59
18.1
10.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
25
156
1.73
1.56
6.0
3.4
umol/l
12.6
13.3
0.19
25
151
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
12
58
2.17
1.53
1.5
2.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
23
142
1.74
1.49
5.9
3.5
g/l
2.6
2.6
0.22
23
133
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
28
2.57
1.47
1.1
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
28
2.57
1.47
7.9
11.9
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
16
3.19
1.44
5.8
5.7
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
5
16
3.19
1.44
5.6
5.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
22
2.80
1.44
4.7
3.6
%
45.7
46.2
—
6
22
(3026008) Bacteria identified in Urine by Culture
33
228
1.59
1.41
4.1
2.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
43
316
1.53
1.41
14.1
10.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
17
3.00
1.36
20.2
8.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
12
61
2.06
1.36
7.3
6.6
%
0.6
0.5
—
7
19
(3037467) Urinalysis macro (dipstick) panel - Urine
73
601
1.46
1.35
6.0
4.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
45
337
1.50
1.34
12.0
10.1
mmol/l
1.7
0.9
1.27
37
255
(3021447) Carbon dioxide [Partial pressure] in Venous blood
45
337
1.50
1.34
12.0
10.0
kpa
6.0
5.7
1.36
45
328
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
84
1.88
1.32
1.5
1.4
—
—
—
0
0
(3010421) pH of Blood
6
24
2.56
1.31
17.0
5.8
ph
7.4
7.4
—
6
24
(3013290) Carbon dioxide [Partial pressure] in Blood
6
24
2.56
1.31
16.8
5.8
kpa
5.4
4.8
—
6
24
(3027315) Oxygen [Partial pressure] in Blood
6
24
2.56
1.31
10.2
5.8
kpa
7.9
9.0
—
6
24
(3009542) Hematocrit [Volume Fraction] of Blood
121
1114
1.85
1.30
20.2
16.7
%
38.3
38.2
0.02
114
1016
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
44
2.11
1.29
1.6
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
19
117
1.72
1.25
2.6
2.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
11
195
0.52
1.24
1.4
1.4
—
110.6
—
0
8
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
22
142
1.65
1.23
2.4
2.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
19
2.68
1.22
1.4
2.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
19
118
1.71
1.22
2.4
2.0
—
—
—
0
0
(3044889) 12 lead EKG panel
47
363
1.45
1.19
2.4
2.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
34
0.00
1.17
0.0
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
25
169
1.58
1.17
2.2
1.9
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
20
2.55
1.15
1.2
1.1
—
—
—
0
0
(3020891) Body temperature
5
20
2.55
1.15
14.4
6.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
16
96
1.75
1.15
2.4
1.9
u/ml
269.2
145.7
—
5
42
(3035637) Corticotropin [Mass/volume] in Plasma
12
66
1.89
1.12
1.6
1.8
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
43
330
1.44
1.11
12.2
10.0
kpa
5.3
5.2
0.01
43
322
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
43
330
1.44
1.11
18.8
10.0
mmol/l
24.6
24.1
0.86
43
330
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
16
97
1.73
1.11
2.4
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
7
32
2.24
1.09
2.3
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
45
350
1.42
1.08
20.3
10.7
mmol/l
1.5
0.9
0.80
38
258
(3015235) Bicarbonate [Moles/volume] in Capillary blood
9
45
2.06
1.07
12.4
14.0
mmol/l
25.1
23.1
—
9
40
(44790047)
9
46
2.02
1.06
1.6
2.0
—
—
—
0
0
(44790048)
9
46
2.02
1.06
1.6
2.0
—
—
—
0
0
(44806118)
9
46
2.02
1.06
1.6
2.0
—
—
—
0
0
(44790049)
9
46
2.02
1.06
1.6
2.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
42
324
1.43
1.05
6.0
9.9
mmol/l
24.1
23.5
1.21
42
314
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
22
2.31
1.04
4.8
3.5
e9/l
3.0
2.8
—
5
22
(3020717) Zinc [Moles/volume] in Serum or Plasma
5
22
2.31
1.04
2.8
2.3
umol/l
11.6
12.2
—
5
22
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
29
0.00
0.99
0.0
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
28
0.00
0.99
0.0
1.2
—
71.1
—
0
28
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
28
0.00
0.99
0.0
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
18
118
1.60
0.96
3.7
4.8
ng/l
1273.8
1239.8
0.01
11
86
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
44
538
0.73
0.95
1.9
2.0
u/ml
1.4
4.0
—
7
85
(3045414) Leukocytes [Presence] in Urine
6
27
2.27
0.94
1.7
1.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
106
1132
0.68
0.94
4.3
4.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
68
578
1.35
0.94
7.9
10.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
8
42
1.96
0.90
1.4
4.2
g/l
65.9
63.2
—
8
42
(3019230) Fractional oxyhemoglobin in Venous blood
8
42
1.96
0.90
1.8
24.1
%
81.4
74.6
—
8
42
(3024561) Albumin [Mass/volume] in Serum or Plasma
41
327
1.36
0.84
15.8
9.4
g/l
36.5
37.3
0.33
41
313
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
48
393
1.34
0.83
20.4
14.6
mmol/l
25.1
24.6
0.55
48
393
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
50
412
1.33
0.83
5.4
3.6
mmol/mol
36.3
38.2
0.48
44
387
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
25
0.00
0.80
0.0
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
27
0.00
0.78
0.0
2.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
49
406
1.32
0.77
11.2
5.8
ml/min/173m2
117.2
111.8
0.46
24
243
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
23
2.21
0.77
1.2
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
23
2.21
0.77
2.0
2.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
5
23
2.21
0.77
6.8
3.0
mmol/l
28.4
34.3
—
5
23
(3000492) Spirometry study
9
56
1.65
0.74
1.4
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
10
60
1.72
0.73
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
39
1.83
0.73
1.3
1.9
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
7
40
1.78
0.72
8.3
4.3
e6/l
0.0
0.1
—
7
40
(3007164) IgA [Mass/volume] in Serum or Plasma
44
520
0.77
0.70
1.6
1.8
g/l
1.5
1.4
0.15
20
244
(3024928) Oxygen saturation in Venous blood
7
43
1.66
0.67
2.0
23.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
101
934
1.32
0.65
25.1
14.6
mmol/l
4.0
4.0
0.24
101
904
(3019550) Sodium [Moles/volume] in Serum or Plasma
101
935
1.31
0.64
25.4
14.7
mmol/l
138.9
139.3
0.70
101
913
(40768797) Stomach Pathology biopsy report
10
63
1.63
0.63
2.1
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
30
1.69
0.62
1.0
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
22
167
1.38
0.61
2.1
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
8
52
1.57
0.60
1.5
2.2
pmol/l
5.1
5.3
—
8
45
(3022493) Free Hemoglobin [Mass/volume] in Plasma
0
21
0.00
0.60
0.0
5.7
—
86.4
—
0
21
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
73
1.55
0.57
3.1
2.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
59
1.56
0.56
2.3
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
9
61
1.50
0.55
1.3
1.3
pmol/l
676.0
531.1
—
9
55
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
156
0.68
0.54
2.3
2.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
6
40
1.52
0.52
6.7
6.0
ug/l
3.0
2.5
—
6
40
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
17
219
0.74
0.49
1.9
2.4
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
14
102
1.41
0.49
5.5
4.2
nmol/l
31.7
21.8
1.16
14
102
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
21
165
1.32
0.48
2.4
1.4
pmol/l
123.4
98.8
—
9
93
(42529406) Shigella sp [Presence] in Stool by Culture
5
31
1.63
0.43
1.0
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
12
87
1.41
0.43
1.1
2.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
51
567
0.83
0.43
1.8
2.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
10
137
0.71
0.42
1.7
1.8
—
—
—
0
0
(4027681)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
102
0.67
0.41
1.1
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.4
—
39.0
—
0
17
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
35
1.44
0.39
1.4
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
35
1.44
0.39
2.6
5.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
9
68
1.34
0.38
8.6
3.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
124
1205
1.35
0.33
23.6
17.2
e9/l
278.6
278.3
0.01
118
1133
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
74
1.38
0.33
3.3
2.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
23
195
1.21
0.30
5.7
7.0
%
1.4
1.4
0.15
23
188
(40761511) CBC panel - Blood by Automated count
106
1017
1.19
0.30
15.5
8.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
34
300
1.17
0.29
6.3
3.3
mg/l
2.5
2.7
0.21
29
264
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
30
262
1.18
0.29
5.3
3.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
74
693
1.14
0.29
9.9
11.4
e9/l
0.0
0.0
0.00
61
491
(1761868) Lipid panel - Serum or Plasma
9
117
0.75
0.29
1.9
2.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
124
1208
1.31
0.29
23.5
17.1
e12/l
4.6
4.6
0.15
118
1130
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
62
1.30
0.28
1.8
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
124
1209
1.30
0.27
23.4
17.1
e9/l
7.0
7.2
0.18
117
1132
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
53
487
1.14
0.27
1.9
2.2
mmol/l
5.4
5.3
0.18
47
436
(3016879) Cocaine [Presence] in Urine
13
105
1.26
0.25
1.0
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
168
0.81
0.25
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
37
1.36
0.24
1.4
2.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
39
1.29
0.23
2.6
2.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
5
40
1.26
0.22
9.6
24.2
u/ml
0.3
0.3
—
5
29
(3025941) Bacteria identified in Stool by Culture
5
40
1.26
0.22
1.0
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
79
751
1.12
0.22
9.7
11.7
e9/l
3.1
3.3
0.49
71
598
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
173
1.18
0.22
2.2
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
42
1.19
0.21
1.4
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
2.2
—
0
6
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
21
183
1.17
0.21
6.4
3.6
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
30.0
—
0.6
—
0
13
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
204.0
—
0
13
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
7.4
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.3
—
27.5
—
0
14
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.2
—
3.0
—
0
8
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
49
456
1.11
0.20
3.9
3.2
mmol/l
4.1
4.3
0.93
44
432
(3027944) Amphetamines [Presence] in Urine
13
109
1.21
0.19
1.2
2.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
15
128
1.19
0.18
1.7
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
57
1.24
0.18
1.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
11
131
0.82
0.18
2.0
2.0
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
7
59
1.19
0.18
1.0
1.1
—
4.8
—
0
6
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
65
0.76
0.17
1.2
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
10
82
1.23
0.17
5.6
4.5
mg/mmol
1119.2
12.4
—
10
74
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
6
78
0.76
0.16
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
111
1.19
0.16
1.2
2.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
111
1.19
0.16
1.2
2.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
112
1.17
0.14
1.2
2.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
109
1065
1.11
0.13
16.4
11.6
mg/l
24.0
24.6
0.08
73
713
(46235355) HIV 1 and 2 tests - Meaningful Use set
24
219
1.11
0.13
2.2
2.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
10
85
1.19
0.12
5.2
4.0
mg/l
145.6
148.4
—
10
77
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
46
436
1.08
0.12
3.8
3.0
mmol/l
2.5
2.6
0.04
41
408
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
43
1.17
0.10
1.2
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
44
1.14
0.10
2.4
1.7
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
45
1.11
0.10
2.2
6.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
46
439
1.07
0.09
3.8
2.9
mmol/l
1.4
1.4
0.02
41
412
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
47
1.06
0.09
1.4
2.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
47
1.06
0.09
2.0
6.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
5
48
1.04
0.09
1.8
5.7
mmol/l
2.4
3.4
—
5
48
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
5
48
1.04
0.09
2.0
6.1
e6/l
171.0
3.3
—
5
32
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
5
48
1.04
0.09
2.0
6.1
e6/l
17597.8
924.9
—
5
32
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
18
165
1.10
0.08
1.7
1.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
74
719
1.06
0.08
8.9
9.7
e9/l
0.0
0.0
0.30
66
562
(3014007) Fractional oxyhemoglobin in Arterial blood
5
60
0.82
0.08
47.4
16.4
%
86.5
95.7
—
5
60
(40760892) CBC W Ordered Manual Differential panel - Blood
19
204
0.92
0.08
11.7
5.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
78
760
1.06
0.08
3.2
3.1
pmol/l
14.4
14.3
0.04
70
702
(3003327) Ova and parasites identified in Stool by Light microscopy
8
75
1.07
0.07
1.5
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
9
85
1.06
0.07
2.0
2.7
u/l
23.8
31.4
—
9
66
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
8
90
0.88
0.07
1.1
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
39
374
1.06
0.06
6.9
5.3
u/l
24.7
26.9
0.17
39
363
(36660697) Celiac disease serology panel - Serum
23
241
0.94
0.05
1.1
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
91
1.10
0.04
1.0
2.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
21
200
1.06
0.03
6.1
3.5
estimate
0.0
0.0
—
9
67
(3019198) Lymphocytes [#/volume] in Blood
75
737
1.03
0.03
9.2
9.6
e9/l
2.6
2.6
0.19
68
609
(42870560) Thyrotropin [Units/volume] in Cord blood
12
128
0.93
0.03
1.0
1.0
mu/l
14.0
7.4
1.00
12
119
(3001604) Monocytes [#/volume] in Blood
73
721
1.02
0.01
9.0
9.6
e9/l
0.6
0.6
0.08
65
564
(3013512) EKG study
10
95
1.05
0.00
1.6
3.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
85
842
1.02
0.00
3.9
3.4
mu/l
2.3
2.1
0.43
78
788
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
22
224
0.98
0.00
1.9
2.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
17
174
0.97
0.00
4.2
2.7
nmol/l
282.2
348.7
0.76
17
166
(4146454)
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
9
0.00
0.00
0.0
1.1
—
188.0
—
0
9
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.0
—
0.5
—
0
5
(3004588) Protein electrophoresis panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
97.1
—
0
9
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
0.3
—
0
9
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.6
—
570.4
—
0
5
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
78
0.89
0.00
1.0
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
90
1.00
0.00
1.2
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
5
50
1.00
0.00
2.0
5.8
mg/l
1223.0
457.4
—
5
50
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
7.7
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
33.8
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint P16_CARDIOV_DISORD_ORIGINA_PERINA_PERIOD and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| P16_CARDIOV_DISORD_ORIGINA_PERINA_PERIOD | 8.691 [4.36, 17.33] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.094 |
During the follow-up period (1.1.1998 — 31.12.2019), 54 out of 3415 females with P16_CARDIOV_DISORD_ORIGINA_PERINA_PERIOD died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have P16_CARDIOV_DISORD_ORIGINA_PERINA_PERIOD.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.626% | No data |
| 5 | 4.213% | No data |
| 10 | 11.306% | No data |
| 15 | 21.689% | No data |
| 20 | 35.607% | No data |
Relationships between endpoints
↥Index endpoint: P16_CARDIOV_DISORD_ORIGINA_PERINA_PERIOD – Cardiovascular disorders originating in the perinatal period
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data